肌萎缩侧索硬化
遗传学
错义突变
基因
生物
遗传异质性
突变
TARDBP公司
基因检测
SOD1
生物信息学
人口
疾病
医学
表型
病理
突变体
环境卫生
作者
Hee-Jung Kim,Ki‐Wook Oh,Min‐Jung Kwon,Seong‐il Oh,Jinseok Park,Young-Eun Kim,Byung‐Ok Choi,Seungbok Lee,Chang‐Seok Ki,Seung Hyun Kim
标识
DOI:10.1016/j.neurobiolaging.2015.09.012
摘要
Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disease involving motor neurons. Because a growing number of genes have been identified as the genetic etiology of ALS, simultaneous screening of mutations in multiple genes is likely to be more efficient than gene-by-gene testing. In this study, we performed a multigene panel testing by using targeted capture of 18 ALS-related genes followed by next-generation sequencing. Using this technique, we tried to identify mutations in 4 index patients with familial ALS and 148 sporadic ALS in Korean population and identified 4 known mutations in SOD1, ALS2, MAPT, and SQSTM1 genes, respectively, and 28 variants of uncertain significance in 9 genes. Among the 28 variants of uncertain significance, 6 missense variants were found in highly conserved residues and were consistently predicted to be deleterious by in silico analyses. These results suggest that multigene panel testing is an effective approach for mutation screening in ALS-related genes. Moreover, the relatively low frequency of mutations in known ALS genes implies marked genetic heterogeneity at least in Korean patients with ALS.
科研通智能强力驱动
Strongly Powered by AbleSci AI